Characteristics of included patients
| Characteristic . | Patients with SCD VOE (N = 3078) . |
|---|---|
| Age, median (IQR)∗, y | 31 (24-38) |
| Sex, n (%) | |
| Male | 1379 (44.8) |
| Female | 1699 (55.2) |
| Organ dysfunctions present on admission, n (%) | |
| Cardiac | 36 (1.2) |
| Respiratory | 91 (3.0) |
| Neurologic | 22 (0.7) |
| Hematologic | 112 (3.6) |
| Hepatic | 3 (0.1) |
| Renal | 151 (4.9) |
| Comorbidity Severity Score, points (IQR) | 1 (0-2) |
| Hemoglobin concentration on the day of admission, median (IQR)∗,†, g/dL | 8.3 (7.3-9.6) |
| HU use on day of admission, n (%) | 799 (26.0) |
| Characteristic . | Patients with SCD VOE (N = 3078) . |
|---|---|
| Age, median (IQR)∗, y | 31 (24-38) |
| Sex, n (%) | |
| Male | 1379 (44.8) |
| Female | 1699 (55.2) |
| Organ dysfunctions present on admission, n (%) | |
| Cardiac | 36 (1.2) |
| Respiratory | 91 (3.0) |
| Neurologic | 22 (0.7) |
| Hematologic | 112 (3.6) |
| Hepatic | 3 (0.1) |
| Renal | 151 (4.9) |
| Comorbidity Severity Score, points (IQR) | 1 (0-2) |
| Hemoglobin concentration on the day of admission, median (IQR)∗,†, g/dL | 8.3 (7.3-9.6) |
| HU use on day of admission, n (%) | 799 (26.0) |